Aprus Bio-Medical Innovations Private Limited, a active private limited company, was established on 09 March 2016 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24233KA2016PTC086773. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.85 M.
It upholds a compliant status. Its leadership includes Anand Iyer (Director), Ayyavu Ramachandran (Director), Sunil Shekar Koppa Somashekara (Director). Past directors included Sunil Shekar Koppa Somashekara. Its latest AGM occurred on 27 November 2020, with the balance sheet filed on 31 March 2020. It is based at Bangalore Helix Biotech Park Electronic City Phase I, Bangalore, Karnataka, 560100.
U24233KA2016PTC086773
086773
09 March 2016
₹1.00 M
₹0.85 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Aprus Bio-Medical Innovations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Iyer | Director | 09 Mar 2016 | Current |
| Ayyavu Ramachandran | Director | 09 Mar 2016 | Current |
| Sunil Shekar Koppa Somashekara | Director | 31 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aprus Bio-Medical Innovations Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Aprus Bio-Medical Innovations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aprus Bio-Medical Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aprus Bio-Medical Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprus Bio-Medical Innovations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aprus Bio-Medical Innovations Private Limited last Annual general meeting of members was held on 27 Nov 2020 as per latest MCA records. was completed.
Progress on Sunil Shekar Koppa Somashekara was appointed as a Director was appointed as a Director on 31 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
Progress on Aprus Bio-Medical Innovations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore. was documented.
Progress on Anand Iyer was appointed as a Director was appointed as a Director on 09 Mar 2016 & has been associated with this company since 9 years 8 months . was documented.
Progress on Ayyavu Ramachandran was appointed as a Director was appointed as a Director on 09 Mar 2016 & has been associated with this company since 9 years 8 months . was documented.
The activity Aprus Bio-Medical Innovations Private Limited was registered on 09 Mar 2016 with Roc Bangalore & aged 9 years 8 months as per MCA records. was completed.
The CIN of Aprus Bio-Medical Innovations Private Limited is U24233KA2016PTC086773.
Aprus Bio-Medical Innovations Private Limited is headquartered at Bangalore Helix Biotech Park Electronic City Phase I, Bangalore, Karnataka, 560100.
Aprus Bio-Medical Innovations Private Limited was incorporated on 09 March 2016.
The current directors of Aprus Bio-Medical Innovations Private Limited are
The primary industry of Aprus Bio-Medical Innovations Private Limited is Pharma.
Aprus Bio-Medical Innovations Private Limited is unlisted.
The authorized capital of Aprus Bio-Medical Innovations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.85 M.
The compliance status of Aprus Bio-Medical Innovations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX